Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP) (SPI) and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) announced that the U.S. Food and Drug Administration ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE